Climbs
Sort by
3 items
Filter
Items per page
-
Acrivon Therapeutics’ shares climb 14% on plans to present cancer-test data
Shares of Acrivon Therapeutics advanced in post-market trading after the biopharmaceutical company said it would present clinical trial data in connection with a biomarker test for ovarian and endometrial cancers.MarketWatch - Business -
Stock-market pessimism is climbing. Why it’s still not bad enough to imply stocks hit a bottom.
Stocks could have more room to fall before they touch bottom, says Tom Essaye, founder of Sevens Report Research.MarketWatch - Business -
Mortgage rates climb for fourth week in a row, taking ‘the wind out of the sails’ of the housing market
The 30-year mortgage rate is averaging 7.17%, Freddie Mac said in its latest weekly survey on Thursday.MarketWatch - Business - Mortgage